Periapical bone regeneration after endodontic microsurgery with three different root-end filling materials: amalgam, SuperEBA, and mineral trioxide aggregate.
BACKGROUND
The purpose of this study was to determine the bone regeneration potential to different root-end filling materials by evaluating the distance between the materials and newly regenerated bone after root-end surgery.


METHODS
Periapical lesions were induced in premolars and molars of five female beagle dogs. The teeth were treated endodontically after the development of the lesions. After 1 week, the teeth underwent root-end surgery using modern microsurgical techniques. Three different root-end filing materials were used: amalgam (Tytin; Kerr Mfg Co, Romulus, MI), SuperEBA (Bosworth, Skokie, IL), and mineral trioxide aggregates (MTA; Dentsply, York, PA). After 4 months, the dogs were sacrificed, and the jaws were prepared for histological sectioning. The distances from the root-end filling materials to the regenerated bone were determined by the evaluation of microradiographic images of the sections with imaging software (Sigma Scan/Image; Jandel Scientific Software, San Rafael, CA). The results were statistically analyzed with analysis of variance using Sigma Stat software (Jandel Scientific Software, San Rafael, CA).


RESULTS
The mean distances from the newly regenerated bone were 0.397 +/- 0.278 mm in the MTA group, 0.756 +/- 0.581 mm in the SuperEBA group, and 1.290 +/- 0.386 mm in the amalgam group. There was a statistically significant difference between the amalgam and MTA groups (p < 0.05). No significant differences existed for amalgam versus SuperEBA and SuperEBA versus MTA.


CONCLUSIONS
MTA showed the most favorable periapical tissue response. The distance from MTA to the regenerated bone was similar to the normal average periodontal ligament thickness in dogs.
Baek
Seung-Ho
SH
Department of Conservative Dentistry, School of Dentistry, Seoul National University, Seoul, Korea.
Lee
Woo Cheol
WC
Setzer
Frank C
FC
Kim
Syngcuk
S
D017607:Aluminum Compounds / Q000627:therapeutic use; D000539:Alveolar Process / Q000187:drug effects / Q000503:physiopathology*; D000818:Animals; D001047:Apicoectomy / Q000379:methods*; D001641:Bicuspid / Q000473:pathology; D001861:Bone Regeneration / Q000187:drug effects / Q000502:physiology*; D017610:Calcium Compounds / Q000627:therapeutic use; D003722:Dental Alloys / Q000627:therapeutic use; D003723:Dental Amalgam / Q000627:therapeutic use; D017220:Dentin-Bonding Agents / Q000627:therapeutic use; D004285:Dogs; D004338:Drug Combinations; D005260:Female; D007091:Image Processing, Computer-Assisted; D008852:Microradiography; D008866:Microsurgery / Q000379:methods*; D008963:Molar / Q000473:pathology; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology; D010087:Oxides / Q000627:therapeutic use; D010483:Periapical Diseases / Q000628:therapy; D010486:Periapical Tissue / Q000187:drug effects / Q000503:physiopathology*; D010513:Periodontal Ligament / Q000187:drug effects / Q000503:physiopathology; D011897:Random Allocation; D012184:Retrograde Obturation / Q000379:methods*; D012387:Root Canal Filling Materials / Q000627:therapeutic use*; D017640:Silicates / Q000627:therapeutic use
D017607:Aluminum Compounds; D017610:Calcium Compounds; D003722:Dental Alloys; D017220:Dentin-Bonding Agents; D004338:Drug Combinations; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; C086631:mineral trioxide aggregate; C036886:tytin; D003723:Dental Amalgam; C084074:Super EBA